Benzinga | Feb 26, 2021 08:36AM EST

Morgan Stanley Maintains Equal-Weight on Clarivate, Lowers Price Target to $28

Morgan Stanley analyst Toni Kaplan maintains Clarivate (NYSE:CLVT) with a Equal-Weight and lowers the price target from $30 to $28.